Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Crazy
Uh oh
Don’t blink
This could easily go red…
Machines just trading cards .02 spread mm showing 100 share on both sides
Nothing to see here
Gaxos Partners with Meshy to Deliver AI-Generated 3D Models in its Product for Game Developers and Publishers
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
Virpax Announces Positive Results of Swine Model Pilot Study for Probudur
Uh oh spaghetti o
the scent of a burnt piece of meat
VIVOPOWER SECURES EXTENSION FOR US$34M LOAN FINANCING FACILITY AGREEMENT
U.S. Energy Corp. Announces Entry Into Binding Agreement For Asset Sale For South Texas Properties
On July 9, 2024, Soligenix, Inc. (the “Company”) entered into a warrant inducement agreement (the “Inducement Agreement”) with certain holders (the “Holders”) of the Company’s existing Warrant to Purchase Shares of Common Stock (“Existing Warrants”) to purchase shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company. Pursuant to the Inducement Agreement, the Holders agreed to exercise for cash their Existing Warrants to purchase up to 703,125 shares of Common Stock at an exercise price of $6.00 per share during the period from the date of the Inducement Agreement until 1:30 p.m., Eastern Time, on July 9, 2024. The aggregate gross proceeds to be received by the Company will depend on the number of Existing Warrants actually exercised by the Holders. If all of the Existing Warrants are exercised in connection with the Inducement Agreement, the Company would anticipate receiving aggregate gross proceeds of up to approximately $4,218,750 from the exercise of the Existing Warrants before deducting financial advisory fees and other expenses payable by us. There is, however, no guarantee that all of the Existing Warrants will be exercised by the Holder in accordance with the Inducement Agreement.
Oh cmon
Too good
Damn
Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
Source: PR Newswire (US)
Study Supported by $2.6 Million FDA Orphan Products Development Grant
Don’t mess with ARCX mm never disappoints
What leaked
Professional squeeze
The manipulation here is real…
60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
Pineapple Energy Formalizes Agreement With Conduit Capital for Services and to Pursue Working Capital Investment
LOL
Look at these pros squeeeze them
So unnecessary
Yawn….
Oh cmon
lol
VIVOPOWER’S TEMBO CONFIRMS HEADS OF AGREEMENT EXCLUSIVITY EXTENSION FOR US$838M MERGER WITH CCTS
lol
JX Luxventure Signs Blockbuster USD100,000,000 (3X 2023 Revenue) Sales Agreement
Probably that lawsuit…
Damn
Datasea Enters into New Sales Agreements for its 5G AI Communications and High Tech Acoustic Segments Expecting $62 Million in Sales
XTI Aerospace Signs Capital Distribution Agreement for Proposed Investment of up to $55 Million at $275 Million Valuation
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million